NCT07204015Not yet recruiting
Body Composition in Pediatric Patients With Thalassemia Major
Body Composition in Pediatric Patients With Thalassemia Major Attending Assiut University Children's Hospital
Source: ClinicalTrials.gov · Last updated 2 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To assess body composition (fat mass, lean mass, and bone mass) in pediatric patients with beta thalassemia major using appropriate tools (e.g.,Bioelectrical impedance analysis (BIA)). To evaluate the association between body composition and clinical parameters such as transfusion frequency, nutritional status, serum ferritin levels, endocrine complications.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 115 (estimated)
- First submitted
- 24 Sept 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Oct 2026
- Lead sponsor
- Assiut University
- Diseases
- Thalassaemia
- NCT number
- NCT07204015
What you commit to
- Study type: Observational
- Planned participants: 115
- From 1 Oct 2025 to the primary completion date, 1 Oct 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- On medications that significantly affect body composition (e.g., steroids)
Other illness
- Presence of other chronic systemic diseases
Other
- Severe physical or cognitive disability interfering with assessment
Who the study is looking for
- Children aged 5-18 years
- Diagnosed with beta thalassemia major
- Receiving regular transfusions
- Informed consent/assent provided.
Age in the registry: 5 years to 18 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.